Synergistic impact of resection margin and microscopic vascular invasion for patients with HBV-related intrahepatic cholangiocarcinoma

References

• Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology. 2001;33(6):1353–1357.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Colombet M, Soerjomataram I, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356–387.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29.
   PubMed Web of Science ®Google Scholar
• Yang F, Ma L, Yang Y, et al. Contribution of Hepatitis B virus infection to the aggressiveness of primary Liver Cancer: a clinical epidemiological study in Eastern China. Front Oncol. 2019;9:370.
   PubMed Web of Science ®Google Scholar
• De Jong MC, Nathan H, Sotiropoulos GC, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol. 2011;29(23):3140–3145.
   PubMed Web of Science ®Google Scholar
• Massa A, Varamo C, Vita F, et al. Evolution of the experimental models of cholangiocarcinoma. Cancers (Basel). 2020;12(8):2308.
   Web of Science ®Google Scholar
• Rizzo A, Ricci AD, Brandi G. Futibatinib, an investigational agent for the treatment of intrahepatic cholangiocarcinoma: evidence to date and future perspectives. Expert Opin Investig Drugs. 2020; 10(25): 1–8.
   Web of Science ®Google Scholar
• Nathan H, Aloia TA, Vauthey JN, et al. A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2009;16(1):14–22.
   PubMed Web of Science ®Google Scholar
• Shin S, Kim TS, Lee JW, et al. Is the anatomical resection necessary for single hepatocellular carcinoma smaller than 3 cm?: single-center experience of liver resection for a small HCC. Ann Hepatobiliary Pancreat Surg. 2018;22(4):326–334.
   PubMedGoogle Scholar
• Shao C, Chen J, Chen J, et al. Histological classification of microvascular invasion to predict prognosis in intrahepatic cholangiocarcinoma. Int J Clin Exp Pathol. 2017;10(7):7674–7681.
   PubMed Web of Science ®Google Scholar
• Zhao H, Chen C, Gu S, et al. Anatomical versus non-anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: a propensity score matching analysis. J Gastroenterol Hepatol. 2017;32(4):870–878.
   PubMed Web of Science ®Google Scholar
• Tamandl D, Herberger B, Gruenberger B, et al. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2008;15(10):2787–2794.
   PubMed Web of Science ®Google Scholar
• Spolverato G, Yakoob MY, Kim Y, et al. The impact of surgical margin status on long-term outcome after resection for intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2015;22(12):4020–4028.
   PubMed Web of Science ®Google Scholar
• Li MX, Bi XY, Li ZY, et al. Impaction of surgical margin status on the survival outcome after surgical resection of intrahepatic cholangiocarcinoma: a systematic review and meta-analysis. J Surg Res. 2016;203(1):163–173.
   PubMed Web of Science ®Google Scholar
• Ma KW, Cheung TT, She WH, et al. The effect of wide resection margin in patients with intrahepatic cholangiocarcinoma: a single-center experience. Medicine (Baltimore). 2016;95(28):e4133.
   PubMed Web of Science ®Google Scholar
• Strasberg SM, Phillips C. Use and dissemination of the brisbane 2000 nomenclature of liver anatomy and resections. Ann Surg. 2013;257(3):377–382.
   PubMed Web of Science ®Google Scholar
• Sempoux C, Jibara G, Ward SC, et al. Intrahepatic cholangiocarcinoma: new insights in pathology. Semin Liver Dis. 2011;31(1):49–60.
   PubMed Web of Science ®Google Scholar
• Hu LS, Weiss M, Popescu I, et al. Impact of microvascular invasion on clinical outcomes after curative-intent resection for intrahepatic cholangiocarcinoma. J Surg Oncol. 2019;119(1):21–29.
   PubMed Web of Science ®Google Scholar
• Clavien PA, Barkun J, De Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–196.
   PubMed Web of Science ®Google Scholar
• Zhang XF, Chakedis J, Bagante F, et al. Implications of intrahepatic cholangiocarcinoma etiology on recurrence and prognosis after curative-intent resection: a multi-institutional study. World J Surg. 2018;42(3):849–857.
   PubMed Web of Science ®Google Scholar
• Wei Y, Gao F, Zheng D, et al. Intrahepatic cholangiocarcinoma in the setting of HBV-related cirrhosis: differentiation with hepatocellular carcinoma by using Intravoxel incoherent motion diffusion-weighted MR imaging. Oncotarget. 2018;9(8):7975–7983.
   PubMedGoogle Scholar
• Jeong S, Gao L, Tong Y, et al. Prognostic impact of cirrhosis in patients with intrahepatic cholangiocarcinoma following hepatic resection. Can J Gastroenterol Hepatol. 2017;2017:6543423.
   PubMed Web of Science ®Google Scholar
• Tao LY, He XD, Xiu DR. Hepatitis B virus is associated with the clinical features and survival rate of patients with intrahepatic cholangiocarcinoma. Clin Res Hepatol Gastroenterol. 2016;40(6):682–687.
   PubMed Web of Science ®Google Scholar
• Iida H, Kaibori M, Tanaka S, et al. Low incidence of lymph node metastasis after resection of hepatitis virus-related intrahepatic cholangiocarcinoma. World J Surg. 2017;41(4):1082–1088.
   PubMed Web of Science ®Google Scholar
• Yamada T, Nakanishi Y, Okamura K, et al. Impact of serum carbohydrate antigen 19–9 level on prognosis and prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma. J Gastroenterol Hepatol. 2018;33:1626–1633.
   Web of Science ®Google Scholar
• Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362(14):1273–1281.
   PubMed Web of Science ®Google Scholar
• Bridgewater J, Lopes A, Palmer D, et al. Quality of life, long-term survivors and long-term outcome from the ABC-02 study. Br J Cancer. 2016;114(9):965–971.
   PubMed Web of Science ®Google Scholar
• Ebata T, Hirano S, Konishi M, et al. Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer. Br J Surg. 2018;105(3):192–202.
   PubMed Web of Science ®Google Scholar
• Primrose JN, Fox RP, Palmer DH, et al. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol. 2019;20(5):663–673.
   PubMed Web of Science ®Google Scholar
• Spolverato G, Ejaz A, Kim Y, et al. Tumor size predicts vascular invasion and histologic grade among patients undergoing resection of intrahepatic cholangiocarcinoma. J Gastrointest Surg. 2014;18(7):1284–1291.
   PubMed Web of Science ®Google Scholar
• Ma X, Liu L, Fang J, et al. MRI features predict microvascular invasion in intrahepatic cholangiocarcinoma. Cancer Imaging. 2020;20(1):40.
   PubMed Web of Science ®Google Scholar
• Tang Z, Liu WR, Zhou PY, et al. Prognostic value and predication model of microvascular invasion in patients with intrahepatic cholangiocarcinoma. J Cancer. 2019;10(22):5575–5584.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li J, Xia Y, et al. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol. 2013;31(9):1188–1195.
   PubMed Web of Science ®Google Scholar